Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (1): 73-75.DOI: 10.3969/j.issn.1673-8640.2023.01.015
Previous Articles Next Articles
Received:
2022-02-21
Revised:
2022-08-04
Online:
2023-01-30
Published:
2023-03-15
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.01.015
组别 | 例数 | Ang-2/ (ng/mL) | Cc16/ (ng/mL) | PVPI |
---|---|---|---|---|
ARDS组 | 124 | |||
入院时 | 5.65±1.78 | 55.68±14.66 | 2.98±1.32 | |
康复后 | 1.55±0.41 | |||
正常对照组 | 124 | 4.55±1.22 | 28.75±8.54 | |
t值 | 5.676 | 17.675 | 11.521 | |
P值 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | Ang-2/ (ng/mL) | Cc16/ (ng/mL) | PVPI |
---|---|---|---|---|
ARDS组 | 124 | |||
入院时 | 5.65±1.78 | 55.68±14.66 | 2.98±1.32 | |
康复后 | 1.55±0.41 | |||
正常对照组 | 124 | 4.55±1.22 | 28.75±8.54 | |
t值 | 5.676 | 17.675 | 11.521 | |
P值 | 0.000 | 0.000 | 0.000 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
Ang-2 | 0.688(0.626~0.745) | 5.3 ng/mL | 71.77 | 59.68 | 0.314 5 |
Cc16 | 0.941(0.904~0.967) | 37.82 ng/mL | 87.90 | 87.10 | 0.750 0 |
PVPI | 0.832(0.835~0.919) | 2.13 | 93.50 | 75.80 | 0.693 5 |
联合检测模型 | 0.984(0.960~0.996) | 0.87 | 98.40 | 96.00 | 0.943 5 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
Ang-2 | 0.688(0.626~0.745) | 5.3 ng/mL | 71.77 | 59.68 | 0.314 5 |
Cc16 | 0.941(0.904~0.967) | 37.82 ng/mL | 87.90 | 87.10 | 0.750 0 |
PVPI | 0.832(0.835~0.919) | 2.13 | 93.50 | 75.80 | 0.693 5 |
联合检测模型 | 0.984(0.960~0.996) | 0.87 | 98.40 | 96.00 | 0.943 5 |
[1] | 胡小勇, 曹霖, 敬毅, 等. ARDS患者血清NLR、SAA和降钙素原的临床意义及其与预后的关系[J]. 临床和实验医学杂志, 2022, 21(11):1156-1159. |
[2] | 陈武, 林嘉威, 吴生根, 等. 福建省新型冠状病毒肺炎患者密切接触者的流行病学特征与感染危险因素[J]. 中华疾病控制杂志, 2020, 24(5):562-566. |
[3] | 秦妮, 段亚楠, 米婷. 血清降钙素原和C反应蛋白检测对急性呼吸窘迫综合征合并肺部感染患者预后的评估价值[J]. 海南医学, 2019, 30(22):2887-2889. |
[4] | 尹俊, 孙健, 宋振举, 等. 物联网辅助成人急性呼吸窘迫综合征诊治中国专家共识[J]. 中国临床医学, 2022, 29(5):719-730. |
[5] | 徐帆, 朱蕾. 血管生成素2在急性呼吸窘迫综合征中的研究进展[J]. 中华结核和呼吸杂志, 2021, 44(3):267-270. |
[6] |
PLUMMER R, HU G F, LIU T, et al. Angiogenin regulates PKD activation and COX-2 expression induced by TNF-α and bradykinin in the colonic myofibroblast[J]. Biochem Biophys Res Commun, 2020, 525(4):870-876.
DOI URL |
[7] |
PREHN J H M, JIRSTRÖM E. Angiogenin and tRNA fragments in Parkinson's disease and neurodegeneration[J]. Acta Pharmacol Sin, 2020, 41(4):442-446.
DOI PMID |
[8] | 周亚清, 濮尊国, 刘爱明, 等. 急性呼吸窘迫综合征患者呼出气冷凝液中白细胞介素-8、克拉拉细胞蛋白16、细胞间黏附分子-1检测的临床意义[J]. 中国呼吸与危重监护杂志, 2021, 20(12):857-861. |
[9] |
PERI A, MIRKOVI C Š, VOJVODI D. Clara cell protein 16 release from the nasal mucosa in allergic rhinitis,chronic rhinosinusitis,and exposure to air pollutants[J]. Arh Hig Rada Toksikol, 2018, 69(3):215-219.
DOI URL |
[10] |
GULEC BALBAY E, ATAOGLU O, ERCELIK M, et al. Serum Clara cell secretory protein(CC-16) in non-smoking patients with obstructive sleep apnea[J]. Sleep Breath, 2020, 24(4):1607-1612.
DOI |
[11] | 林化, 倪琦, 李超乾. 早期联合监测血管外肺水指数、肺血管通透性指数及血清氨基末端脑钠肽前体评估急性呼吸窘迫综合征患者预后的价值[J]. 实用医学杂志, 2019, 35(11):1813-1815. |
[12] |
KOR D J, WARNER D O, CARTER R E, et al. Extravascular lung water and pulmonary vascular permeability index as markers predictive of postoperative acute respiratory distress syndrome:a prospective cohort investigation[J]. Crit Care Med, 2015, 43(3):665-673.
DOI URL |
[13] | 叶剑滨, 林锦乐, 钟超, 等. 组合检测血管生成素2与克拉拉细胞蛋白16早期诊断急性呼吸窘迫综合征的临床价值[J]. 中华急诊医学杂志, 2019, 26(9):1112-1117. |
[14] | 刘洋, 王英, 梁咏涵, 等. 富含半胱氨酸蛋白61和血管内皮生长因子在大脑中动脉慢性闭塞性病变患者体内表达水平和相互作用研究[J]. 中国脑血管病杂志, 2022, 19(10):677-684. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||